Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
复方清带灌注液 (Compound Qingdai Infusion) is a proprietary Traditional Chinese Medicine (TCM) developed and manufactured by Shaanxi Kanghui Pharmaceutical. It is formulated as a vaginal infusion liquid containing a complex mixture of herbal and mineral ingredients, including bear bile powder (熊胆粉), Sophora flavescens (苦参), Cnidium monnieri (蛇床子), Coptis chinensis (黄连), Pseudolarix kaempferi bark (土荆皮), realgar (雄黄), clove leaf (丁香叶), catechu (儿茶), and calcined alum (白矾). The preparation is indicated for the treatment of various types of vaginitis, including fungal (vulvovaginal candidiasis), trichomonal, and non-specific vaginitis. Its therapeutic actions are characterized in TCM terms as clearing heat, eliminating dampness, killing parasites, and relieving itching. It is administered topically via vaginal infusion and is recognized as an exclusive patented product of the company.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 复方清带灌注液.